Team:Potsdam Bioware

From 2012.igem.org

(Difference between revisions)
(→Project Description)
(→Project Description)
Line 64: Line 64:
!align="center"|[[Team:Potsdam_Bioware/Attributions|Attributions]]
!align="center"|[[Team:Potsdam_Bioware/Attributions|Attributions]]
|}
|}
-
 
-
<html>
 
-
<head>
 
-
<style type="text/css">
 
-
 
-
 
-
.box_round {
 
-
  color: white;
 
-
  padding: 5px;
 
-
  border-radius: 15px;
 
-
  background: #cb9840;
 
-
  background: -moz-linear-gradient(top,  #cb9840 0%, #a77b34 100%);
 
-
  background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,#cb9840), color-stop(100%,#a77b34));
 
-
  background: -webkit-linear-gradient(top,  #cb9840 0%,#a77b34 100%);
 
-
  background: -o-linear-gradient(top,  #cb9840 0%,#a77b34 100%);
 
-
  background: -ms-linear-gradient(top,  #cb9840 0%,#a77b34 100%);
 
-
  background: linear-gradient(to bottom,  #cb9840 0%,#a77b34 100%);
 
-
  filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#cb9840', endColorstr='#a77b34',GradientType=0 );
 
-
  box-shadow:8px 8px 8px #666;
 
-
}
 
-
</head>
 
-
</html>
 

Revision as of 20:41, 24 August 2012

Direct Antibody Identification, Maturation and Production in CHO-Cells

Project Description

Antibodies are versatile molecules for research and therapy and they are currently revolutionizing the market of biopharmaceuticals. To date, antibodies are generated in a laborious and time consuming manner. Either animal immunization followed by hybridoma technology or phage display is used to identify desired genes, which then need to be transferred to a production cell line such as CHO. We designed a streamlined workflow that incorporates all steps of antibody generation in CHO cells. Our plan is to stably transfect an antibody-fragment library in CHO cells. Antibody maturation is mimicked by further diversifying this library using the enzyme Activation-Induced cytidine Deaminase (AID), which is known to induce somatic hypermutation. Next, we plan to test and deploy a versatile and continuous viral selection system for clones producing the desired antibodies. Finally, we will try to employ a genetic switch to go from surface expression to soluble production of antibodies.


Home Team Official Team Profile Project Parts Submitted to the Registry Modeling Notebook Safety Attributions
Retrieved from "http://2012.igem.org/Team:Potsdam_Bioware"